Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species
Mycoses · 2026-03 · 69 (3)
DOI: 10.1111/myc.70155 ↗At a glance
Evaluationsstudie in Mycoses, published online on 2026-03-19. Written by Manuela Loaiza-Oliva and 5 co-authors. Institution: Laboratorio de Micología y Diagnóstico Molecular-Cátedra de Parasitología y Micología-Facultad de Bioquímica, Universidad Nacional del Litoral, Santa…. Major MEDLINE topics: Mannans, Aspergillus, Pulmonary Aspergillosis. 45 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Consejo Nacional de Investigaciones Científicas y Técnicas, JYLAG Foundation.
Abstract (original language)
Background
Although Aspergillus fumigatus remains the primary cause of invasive aspergillosis, other species—including emerging cryptic ones—are increasingly identified in clinical settings. These species often exhibit distinct antifungal susceptibility profiles, emphasising the importance of species‐level identification for effective patient management. Galactomannan, once considered specific to A. fumigatus , is now widely used for aspergillosis diagnosis regardless of species. However, its performance in detecting non‐ fumigatus infections remains insufficiently characterised.
Objective
To evaluate the diagnostic performance of the Sōna GM LFA (IMMY) in BAL samples from patients with pulmonary infections attributed to different Aspergillus spp., including cryptic species.
Methods
We evaluated the diagnostic performance of the Sōna galactomannan LFA (IMMY) in bronchoalveolar lavage samples from 49 patients (15% paediatric) with probable invasive aspergillosis or COVID‐associated pulmonary aspergillosis, confirmed by microscopy and culture.
Results
The etiologic agents comprised A. fumigatus sensu stricto (46.9%), A. terreus ss. (16.3%), A. flavus ss. (16.3%), A. niger ss. (6.1%), A. nidulans (4.1%) and five cryptic species (10.2%). Galactomannan index values varied across species and clinical group, with particularly low readings (0.09–0.31) in six cases (five involving cryptic species), suggesting reduced assay sensitivity for cryptic taxa. Paediatric samples also showed lower galactomannan levels compared to adults.
Conclusions
This study highlights the limitations of galactomannan assays in detecting cryptic Aspergillus infections, showing consistently low galactomannan levels in BAL. Multicenter studies are needed to validate findings and refine clinical algorithms.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Laboratorio de Micología y Diagnóstico Molecular-Cátedra de Parasitología y Micología-Facultad de Bioquímica, Universidad Nacional del Litoral, Santa Fe, Argentina.
- Instituto de Salud y Ambiente del Litoral (ISAL) - Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Santa Fe, Argentina.
- Centro de Especialidades Médicas Ambulatorias de Rosario (CEMAR), Secretaría de Salud Pública de la Municipalidad de Rosario, Rosario, Argentina.
Funding
- Consejo Nacional de Investigaciones Científicas y Técnicas
- JYLAG Foundation
Cite
APA
Loaiza-Oliva, M., Funes, P., Romero, M. M., Barbagelata, M. S., Gamarra, S., & Garcia-Effron, G. (2026). Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species. Mycoses, 69(3). https://doi.org/10.1111/myc.70155
Vancouver
Loaiza-Oliva M, Funes P, Romero MM, Barbagelata MS, Gamarra S, Garcia-Effron G. Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species. Mycoses. 2026;69(3). doi:10.1111/myc.70155
BibTeX
@article{LoaizaOliva2026,
author = {Loaiza-Oliva, Manuela and Funes, Paula and Romero, María Mercedes and Barbagelata, María Sol and Gamarra, Soledad and Garcia-Effron, Guillermo},
title = {Diagnostic Performance of Sōna GM LFA in Pulmonary Infections Caused by Different Aspergillus Species},
journal = {Mycoses},
year = {2026},
volume = {69},
number = {3},
doi = {10.1111/myc.70155}
}
EUVIMED